SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (2387)10/17/1997 12:51:00 PM
From: margie   of 6136
 
Thank you. Hope you are right.

Here's the part from today's WSJ about Merck that mentions Viracept.
I missed it Randy, guess I'm slipping.

"Several other Merck products also have faced unexpected competition from other drugs, the analyst said. For example, she said, the company's anticholesterol drug Zocor has a strong rival in Warner-Lambert Co.'s (WLA) Lipitor, while Crixivan, an AIDS drug that has suffered from falling sales, has gone up against Agouron Pharmaceuticals Inc.'s (AGPH) Viracept."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News